Ocugen, Inc. (OCGN)
1.195
-0.04
(-3.63%)
USD |
NASDAQ |
Jun 10, 16:00
1.19
0.00 (0.00%)
After-Hours: 20:00
Ocugen EPS Diluted (TTM) : -0.2318 for March 31, 2026
EPS Diluted (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical EPS Diluted (TTM) Data
| Date | Value |
|---|---|
| March 31, 2026 | -0.2318 |
| December 31, 2025 | -0.2258 |
| September 30, 2025 | -0.2168 |
| June 30, 2025 | -0.1974 |
| March 31, 2025 | -0.2062 |
| December 31, 2024 | -0.20 |
| September 30, 2024 | -0.1951 |
| June 30, 2024 | -0.1942 |
| March 31, 2024 | -0.2317 |
| December 31, 2023 | -0.2621 |
| September 30, 2023 | -0.321 |
| June 30, 2023 | -0.3765 |
| March 31, 2023 | -0.3699 |
| December 31, 2022 | -0.3807 |
| September 30, 2022 | -0.3522 |
| June 30, 2022 | -0.3051 |
| March 31, 2022 | -0.3476 |
| December 31, 2021 | -0.298 |
| September 30, 2021 | -0.2454 |
| June 30, 2021 | -0.2653 |
| March 31, 2021 | -0.326 |
| December 31, 2020 | -0.3629 |
| September 30, 2020 | -0.107 |
| June 30, 2020 | -3.585 |
| March 31, 2020 | -38.39 |
| Date | Value |
|---|---|
| December 31, 2019 | -114.67 |
| September 30, 2019 | -116.10 |
| June 30, 2019 | -135.93 |
| March 31, 2019 | -108.65 |
| December 31, 2018 | -63.45 |
| September 30, 2018 | -77.57 |
| June 30, 2018 | -67.71 |
| March 31, 2018 | -74.99 |
| December 31, 2017 | -59.80 |
| September 30, 2017 | -82.61 |
| June 30, 2017 | -110.76 |
| March 31, 2017 | -132.36 |
| December 31, 2016 | -152.39 |
| September 30, 2016 | -152.06 |
| June 30, 2016 | -147.00 |
| March 31, 2016 | -145.20 |
| December 31, 2015 | -145.20 |
| September 30, 2015 | -5.40 |
| June 30, 2015 | -21.46 |
| March 31, 2015 | -99.88 |
| December 31, 2014 | -96.88 |
| September 30, 2014 | -399.59 |
| June 30, 2014 | -368.53 |
| March 31, 2014 | -239.70 |
| December 31, 2013 | -238.50 |
EPS Diluted (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (TTM) Benchmarks
| REGENXBIO, Inc. | -5.59 |
| Catalyst Pharmaceuticals, Inc. | 1.740 |
| CytomX Therapeutics, Inc. | -0.3637 |
| Krystal Biotech, Inc. | 7.482 |
| MeiraGTx Holdings Plc | -1.489 |